AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Emsita M 50mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Emsita M 50mg/1000mg Tablet SR

Diabex Duo 50mg/1000mg extended-release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Diabex Duo may be used independently or alongside other diabetes treatments, achieving optimal results when coupled with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and current medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes efficacy; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial for effective diabetes control; lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't suitable for everyone. Inform your doctor of any history of kidney, liver, or heart problems, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Interaction with other medications is possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Emsita M 50mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Emsita M 50mg/1000mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Emsita M 50mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume with food.

Common Side effects of Emsita M 50mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Emsita M 50mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; do not crush, chew, or fracture it. The Emsita M 50mg/1000mg sustained-release tablet should be administered with a meal.

How Emsita M 50mg/1000mg Tablet SR works:

Emsita M 50mg/1000mg Extended-Release tablets combine sitagliptin and metformin to improve blood glucose management. Sitagliptin boosts insulin production from the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Emsita M 50mg/1000mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Emsita M 50mg/1000mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Emsita M 50mg/1000mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Emsita M 50mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. Emsita M 50mg/1000mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Emsita M 50mg/1000mg SR tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Emsita M 50mg/1000mg Tablet SR :

Should you forget to take your Emsita M 50mg/1000mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Emsita M 50mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Emsita M 50mg/1000mg Tablet SR

Emsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Emsita M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Emsita M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita M 50mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 50mg/1000mg SR tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Emsita M 50mg/1000mg SR can cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This rare side effect, linked to metformin, necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Emsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Emsita M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita M 50mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 50mg/1000mg Tablet SR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Emsita M 50mg/1000mg SR tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding Emsita M in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Emsita M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Emsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Emsita M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita M 50mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 50mg/1000mg SR tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Emsita M 50mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding Emsita M in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Emsita M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), requiring supplemental vitamin B12 at least annually, according to some research.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Emsita M 50mg/1000mg Tabl...
151
MRP 175
13% off